Skip to main content

Table 7 Effects of EAF on serum cytokines and liver glycogen contents in T2D rats

From: Antidiabetic effects of Brucea javanica seeds in type 2 diabetic rats

Groups

TNF-α (pg/ml)

IL-6 (pg/ml)

IL-1β (pg/ml)

LG (mg/g tissue)

NDC

28.93 ± 6.48

89.17 ± 3.60

475.97 ± 20.64

15.57 ± 2.63

DC

122.60 ± 11.93a

171.67 ± 8.33a

1041.73 ± 43.71a

6.26 ± 0.67a

D + EAF25

76.77 ± 12.65b

116.94 ± 7.34b

839.76 ± 25.63b

10.11 ± 1.50

D + EAF50

59.10 ± 10.71b

97.78 ± 5.59b

590.97 ± 30.80b

12.67 ± 1.83

D + GLI

70.10 ± 4.00b

123.06 ± 10.18b

570.67 ± 31.71b

11.55 ± 1.82

  1. TNFα tumor necrosis factor-alpha, IL-6 interleukin-6, IL-1β interleukin-1β, LG liver glycogen, NDC non-diabetic control, DC diabetic control, D + EAF25 diabetic rats treated with ethyl acetate fraction 25 mg/kg b.w., D + EAF50 diabetic rats treated with ethyl acetate fraction 50 mg/kg b.w., D + GLI diabetic rats treated with glibenclamide 10 mg/kg b.w. Results are considered significant when p < 0.05
  2. aCompared with NDC, bCompared with DC